• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国放射学院适宜性标准(®)治疗 I 期 T1 声门型喉癌。

American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.

机构信息

Fox Chase Cancer Center, (American College of Surgeons), Philadelphia, Pennsylvania.

出版信息

Head Neck. 2014 Jan;36(1):3-8. doi: 10.1002/hed.23381. Epub 2013 Sep 18.

DOI:10.1002/hed.23381
PMID:23696520
Abstract

BACKGROUND

Controversy surrounds the appropriate therapy for T1 glottic cancer. Both transoral endolaryngeal resection and radiation offer excellent local control and voice quality; some lesions are best addressed with resection and others with radiation.

METHODS

The American College of Radiology (ACR) Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed by a multidisciplinary expert panel. The guideline development includes an analysis of current literature from peer reviewed journals and the well-established "modified Delphi" consensus methodology to rate the appropriateness of treatment. Where evidence is not definitive, expert opinion informed recommendations.

RESULTS

The ACR Expert Panel on Radiation Oncology - Head and Neck Cancer developed consensus recommendations for treatment of T1 glottic cancer. Treatment planning is complex and decisions nuanced.

CONCLUSION

Best treatment for a particular cancer cannot be defined without consideration of the lesion's location, extent, depth of invasion, and quality of surgical exposure during direct laryngoscopy.

摘要

背景

对于 T1 声门型喉癌,争议集中于适当的治疗方法。经口内镜下喉切除术和放射治疗均可提供良好的局部控制和嗓音质量;有些病变最适合采用切除术,而另一些则适合采用放射治疗。

方法

美国放射学院(ACR)适宜性标准是针对特定临床情况的循证指南,由多学科专家小组进行审查。指南制定包括对同行评议期刊的现有文献进行分析,以及经过充分验证的“改良 Delphi”共识方法,以评估治疗的适宜性。在证据不明确的情况下,专家意见指导建议。

结果

美国放射学院头颈部肿瘤放射治疗专家小组就 T1 声门型喉癌的治疗达成了共识建议。治疗计划复杂,决策需要权衡。

结论

如果不考虑直接喉镜检查时病变的位置、范围、浸润深度以及手术暴露的质量,就无法确定特定癌症的最佳治疗方法。

相似文献

1
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancer.美国放射学院适宜性标准(®)治疗 I 期 T1 声门型喉癌。
Head Neck. 2014 Jan;36(1):3-8. doi: 10.1002/hed.23381. Epub 2013 Sep 18.
2
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.ACR 适宜性标准® T1 和 T2 期前列腺癌的明确体外放射治疗。
Am J Clin Oncol. 2011 Dec;34(6):636-47. doi: 10.1097/COC.0b013e3182354a65.
3
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer.ACR 适宜性标准®前列腺癌根治术后放疗。
Oncology (Williston Park). 2014 Dec;28(12):1125-30, 1132-6.
4
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil.ACR 适宜性标准® 同侧放射治疗扁桃体鳞状细胞癌。
Head Neck. 2012 May;34(5):613-6. doi: 10.1002/hed.21993. Epub 2012 Jan 17.
5
Management of T1-T2 glottic carcinomas.T1-T2 声门癌的管理
Cancer. 2004 May 1;100(9):1786-92. doi: 10.1002/cncr.20181.
6
Evidence-based review of treatment options for patients with glottic cancer.基于证据的声门型喉癌治疗方案选择的综述。
Head Neck. 2011 Nov;33(11):1638-48. doi: 10.1002/hed.21528. Epub 2011 Jan 6.
7
ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.ACR 适宜性标准®早期宫颈癌的确定性治疗。
Am J Clin Oncol. 2012 Aug;35(4):399-405. doi: 10.1097/COC.0b013e3182610537.
8
Conservative treatment of early glottic carcinomas with exclusive radiotherapy.早期声门癌单纯放射治疗的保守治疗
Cancer Radiother. 2004 Oct;8(5):288-96. doi: 10.1016/j.canrad.2004.08.003.
9
ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.ACR 适宜性标准®外阴局部晚期鳞状细胞癌的治疗。
Am J Clin Oncol. 2013 Aug;36(4):415-22. doi: 10.1097/COC.0b013e318295af1d.
10
ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer.ACR 适宜性标准® 小细胞肺癌放射治疗。
Am J Clin Oncol. 2013 Apr;36(2):206-13. doi: 10.1097/COC.0b013e31827e5523.

引用本文的文献

1
Evidence and reality: an observational study on pharmacological outcomes in advanced head and neck tumors.证据与现实:一项关于晚期头颈部肿瘤药物治疗结果的观察性研究
Front Oncol. 2025 Jul 25;15:1598125. doi: 10.3389/fonc.2025.1598125. eCollection 2025.
2
Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide.口腔、口咽和喉鳞状细胞癌:全球治疗指南的范围综述
Cancers (Basel). 2023 Sep 3;15(17):4405. doi: 10.3390/cancers15174405.
3
Patterns of Care for Patients With Early-Stage Glottic Cancer Undergoing Definitive Radiation Therapy: A National Cancer Database Analysis.
接受根治性放射治疗的早期声门癌患者的护理模式:一项国家癌症数据库分析
Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1014-1021. doi: 10.1016/j.ijrobp.2017.03.050. Epub 2017 Apr 6.
4
Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma.DNA高甲基化导致GRIM-19表达降低,促进头颈部鳞状细胞癌的有氧糖酵解和细胞增殖。
Oncotarget. 2015 Jan 1;6(1):101-15. doi: 10.18632/oncotarget.2684.
5
Current treatment of T1N0 squamous cell carcinoma of the glottic larynx.声门型喉T1N0鳞状细胞癌的当前治疗方法。
Eur Arch Otorhinolaryngol. 2015 Aug;272(8):1821-4. doi: 10.1007/s00405-014-3388-5. Epub 2014 Nov 8.